QQQ   359.53 (+0.35%)
AAPL   173.42 (+1.29%)
MSFT   318.84 (+0.98%)
META   304.11 (+1.30%)
GOOGL   133.26 (+1.83%)
AMZN   128.82 (+1.34%)
TSLA   249.15 (-0.43%)
NVDA   447.60 (+2.90%)
NIO   8.75 (-3.21%)
BABA   86.16 (-0.67%)
AMD   102.77 (-0.05%)
T   14.76 (-1.73%)
F   12.28 (-1.13%)
MU   67.77 (-0.38%)
CGC   0.73 (-6.26%)
GE   108.52 (-1.84%)
DIS   81.32 (+0.33%)
AMC   8.00 (+0.13%)
PFE   33.68 (+1.54%)
PYPL   58.41 (-0.09%)
NFLX   379.00 (+0.37%)
QQQ   359.53 (+0.35%)
AAPL   173.42 (+1.29%)
MSFT   318.84 (+0.98%)
META   304.11 (+1.30%)
GOOGL   133.26 (+1.83%)
AMZN   128.82 (+1.34%)
TSLA   249.15 (-0.43%)
NVDA   447.60 (+2.90%)
NIO   8.75 (-3.21%)
BABA   86.16 (-0.67%)
AMD   102.77 (-0.05%)
T   14.76 (-1.73%)
F   12.28 (-1.13%)
MU   67.77 (-0.38%)
CGC   0.73 (-6.26%)
GE   108.52 (-1.84%)
DIS   81.32 (+0.33%)
AMC   8.00 (+0.13%)
PFE   33.68 (+1.54%)
PYPL   58.41 (-0.09%)
NFLX   379.00 (+0.37%)
QQQ   359.53 (+0.35%)
AAPL   173.42 (+1.29%)
MSFT   318.84 (+0.98%)
META   304.11 (+1.30%)
GOOGL   133.26 (+1.83%)
AMZN   128.82 (+1.34%)
TSLA   249.15 (-0.43%)
NVDA   447.60 (+2.90%)
NIO   8.75 (-3.21%)
BABA   86.16 (-0.67%)
AMD   102.77 (-0.05%)
T   14.76 (-1.73%)
F   12.28 (-1.13%)
MU   67.77 (-0.38%)
CGC   0.73 (-6.26%)
GE   108.52 (-1.84%)
DIS   81.32 (+0.33%)
AMC   8.00 (+0.13%)
PFE   33.68 (+1.54%)
PYPL   58.41 (-0.09%)
NFLX   379.00 (+0.37%)
QQQ   359.53 (+0.35%)
AAPL   173.42 (+1.29%)
MSFT   318.84 (+0.98%)
META   304.11 (+1.30%)
GOOGL   133.26 (+1.83%)
AMZN   128.82 (+1.34%)
TSLA   249.15 (-0.43%)
NVDA   447.60 (+2.90%)
NIO   8.75 (-3.21%)
BABA   86.16 (-0.67%)
AMD   102.77 (-0.05%)
T   14.76 (-1.73%)
F   12.28 (-1.13%)
MU   67.77 (-0.38%)
CGC   0.73 (-6.26%)
GE   108.52 (-1.84%)
DIS   81.32 (+0.33%)
AMC   8.00 (+0.13%)
PFE   33.68 (+1.54%)
PYPL   58.41 (-0.09%)
NFLX   379.00 (+0.37%)
NASDAQ:OM

Outset Medical (OM) Stock Forecast, Price & News

$10.16
-0.72 (-6.62%)
(As of 01:52 PM ET)
Compare
Today's Range
$10.16
$10.77
50-Day Range
$10.52
$20.58
52-Week Range
$10.16
$30.55
Volume
342,789 shs
Average Volume
516,556 shs
Market Capitalization
$505.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.20

Outset Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
134.3% Upside
$24.20 Price Target
Short Interest
Bearish
15.32% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$475,200 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.42) to ($3.33) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.79 out of 5 stars

Medical Sector

807th out of 969 stocks

Electromedical Equipment Industry

19th out of 20 stocks


OM stock logo

About Outset Medical (NASDAQ:OM) Stock

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Price History

OM Stock News Headlines

Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
What 4 Analyst Ratings Have To Say About Outset Medical
RBC Capital Keeps Their Buy Rating on Outset Medical (OM)
Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
Outset Medical (NASDAQ: OM)
RBC Capital Reaffirms Their Buy Rating on Outset Medical (OM)
Why Shares of Outset Medical Are Down Monday
See More Headlines
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

OM Company Calendar

Last Earnings
8/02/2023
Today
10/02/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
518
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$24.20
High Stock Price Forecast
$29.00
Low Stock Price Forecast
$19.00
Forecasted Upside/Downside
+122.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-162,960,000.00
Net Margins
-131.69%
Pretax Margin
-131.37%

Debt

Sales & Book Value

Annual Sales
$115.38 million
Book Value
$5.09 per share

Miscellaneous

Free Float
47,798,000
Market Cap
$541.72 million
Optionable
Not Optionable
Beta
1.58
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Ms. Leslie L. TriggMs. Leslie L. Trigg (Age 52)
    Pres, CEO & Chairman
    Comp: $1.22M
  • Mr. Nabeel AhmedMr. Nabeel Ahmed (Age 47)
    CFO, Principal Financial Officer & Principal Accounting Officer
    Comp: $654.74k
  • Mr. John L. BrottemMr. John L. Brottem (Age 49)
    Gen. Counsel & Sec.
    Comp: $594.15k
  • Mr. Steven S. WilliamsonMr. Steven S. Williamson (Age 50)
    Chief Commercial Officer
    Comp: $788.51k
  • Marc Nash
    Sr. VP of Operations and R&D
  • Mr. Jean-Olivier Racine (Age 41)
    Chief Technology Officer
  • Mr. James S. Mazzola
    Head of Investor Relations
  • Nicole Shannon
    Director of Marketing Communications
  • Ms. Stacey L. Porter (Age 47)
    Chief People Officer
  • Dr. Michael Aragon M.D.
    Chief Medical Officer













OM Stock - Frequently Asked Questions

Should I buy or sell Outset Medical stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" OM shares.
View OM analyst ratings
or view top-rated stocks.

What is Outset Medical's stock price forecast for 2023?

4 brokerages have issued twelve-month target prices for Outset Medical's shares. Their OM share price forecasts range from $19.00 to $29.00. On average, they anticipate the company's share price to reach $24.20 in the next year. This suggests a possible upside of 122.4% from the stock's current price.
View analysts price targets for OM
or view top-rated stocks among Wall Street analysts.

How have OM shares performed in 2023?

Outset Medical's stock was trading at $25.82 on January 1st, 2023. Since then, OM shares have decreased by 57.9% and is now trading at $10.88.
View the best growth stocks for 2023 here
.

When is Outset Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our OM earnings forecast
.

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings data on Wednesday, August, 2nd. The company reported ($0.90) EPS for the quarter, missing analysts' consensus estimates of ($0.85) by $0.05. The business had revenue of $36.04 million for the quarter, compared to analysts' expectations of $35.18 million. Outset Medical had a negative trailing twelve-month return on equity of 73.66% and a negative net margin of 131.69%.

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $144.00 million-$150.00 million, compared to the consensus revenue estimate of $147.35 million.

When did Outset Medical IPO?

(OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

What is Outset Medical's stock symbol?

Outset Medical trades on the NASDAQ under the ticker symbol "OM."

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Outset Medical's stock price today?

One share of OM stock can currently be purchased for approximately $10.88.

How much money does Outset Medical make?

Outset Medical (NASDAQ:OM) has a market capitalization of $541.72 million and generates $115.38 million in revenue each year. The company earns $-162,960,000.00 in net income (profit) each year or ($3.51) on an earnings per share basis.

How many employees does Outset Medical have?

The company employs 518 workers across the globe.

How can I contact Outset Medical?

Outset Medical's mailing address is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. The official website for the company is outsetmedical.com. The company can be reached via phone at 669-231-8200 or via email at investors@outsetmedical.com.

This page (NASDAQ:OM) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -